Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
archive
biotech
boston blog main
boston top stories
clinical trials
life sciences
medical
national blog main
alirocumab
alnylam pharmaceuticals
amgen
biotech ipos
boston
deals
dyne therapeutics
evolocumab
inclisiran
medicine
metacrine
myotonic dystrophy type 1
national top stories
new york
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
pcsk9
pcsk9 inhibitors
rare disease drugs
rare diseases
recalls
regeneron pharmaceuticals
research
rna interference
salk institute
san diego blog main
san diego top stories
sanofi
the medicines company
What
company
drug
4
×
brings
compound
fda
medicines
acquire
administration
agreed
bacteria
based
billion
brand
breakthrough
cash
cholesterol
class
deal
depression
designation
developing
disorder
disorders
drugs
dyne
dyne’s
food
genetic
gets
granted
ipo
major
mdd
medco
medication
microbiolog
migraine
million
mus
muscle
Language
unset
4
×
Current search:
company���s
×
drug
×
unset
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@slashgear.com
4 years ago
Another company gets FDA designation to treat depression with psilocybin
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@slashgear.com
4 years ago
Popular migraine drug recalled over potentially serious bacteria risk
